BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9573546)

  • 1. Human kallikrein gene delivery protects against gentamycin-induced nephrotoxicity in rats.
    Murakami H; Yayama K; Chao L; Chao J
    Kidney Int; 1998 May; 53(5):1305-13. PubMed ID: 9573546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenovirus-mediated kallikrein gene delivery reverses salt-induced renal injury in Dahl salt-sensitive rats.
    Chao J; Zhang JJ; Lin KF; Chao L
    Kidney Int; 1998 Oct; 54(4):1250-60. PubMed ID: 9767541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrial natriuretic peptide gene delivery attenuates gentamycin-induced nephrotoxicity in rats.
    Murakami H; Yayama K; Chao J; Chao L
    Nephrol Dial Transplant; 1999 Jun; 14(6):1376-84. PubMed ID: 10382996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human kallikrein gene delivery attenuates hypertension, cardiac hypertrophy, and renal injury in Dahl salt-sensitive rats.
    Chao J; Zhang JJ; Lin KF; Chao L
    Hum Gene Ther; 1998 Jan; 9(1):21-31. PubMed ID: 9458239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human tissue kallikrein gene delivery attenuates hypertension, renal injury, and cardiac remodeling in chronic renal failure.
    Wolf WC; Yoshida H; Agata J; Chao L; Chao J
    Kidney Int; 2000 Aug; 58(2):730-9. PubMed ID: 10916096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene therapy in hypertension: adenovirus-mediated kallikrein gene delivery in hypertensive rats.
    Jin L; Zhang JJ; Chao L; Chao J
    Hum Gene Ther; 1997 Oct; 8(15):1753-61. PubMed ID: 9358025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kallikrein gene delivery attenuates hypertension and cardiac hypertrophy and enhances renal function in Goldblatt hypertensive rats.
    Yayama K; Wang C; Chao L; Chao J
    Hypertension; 1998 May; 31(5):1104-10. PubMed ID: 9576121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kallikrein/kinin protects against gentamicin-induced nephrotoxicity by inhibition of inflammation and apoptosis.
    Bledsoe G; Crickman S; Mao J; Xia CF; Murakami H; Chao L; Chao J
    Nephrol Dial Transplant; 2006 Mar; 21(3):624-33. PubMed ID: 16401625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenovirus-mediated kallikrein gene delivery attenuates hypertension and protects against renal injury in deoxycorticosterone-salt rats.
    Dobrzynski E; Yoshida H; Chao J; Chao L
    Immunopharmacology; 1999 Oct; 44(1-2):57-65. PubMed ID: 10604525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human adrenomedullin gene delivery protects against cardiac hypertrophy, fibrosis, and renal damage in hypertensive dahl salt-sensitive rats.
    Zhang JJ; Yoshida H; Chao L; Chao J
    Hum Gene Ther; 2000 Sep; 11(13):1817-27. PubMed ID: 10986555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central delivery of human tissue kallikrein gene reduces blood pressure in hypertensive rats.
    Wang C; Chao C; Madeddu P; Chao L; Chao J
    Biochem Biophys Res Commun; 1998 Mar; 244(2):449-54. PubMed ID: 9514899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental kallikrein gene therapy in hypertension, cardiovascular and renal diseases.
    Chao J; Chao L
    Pharmacol Res; 1997 Jun; 35(6):517-22. PubMed ID: 9356201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue kallikrein attenuates salt-induced renal fibrosis by inhibition of oxidative stress.
    Zhang JJ; Bledsoe G; Kato K; Chao L; Chao J
    Kidney Int; 2004 Aug; 66(2):722-32. PubMed ID: 15253727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal phenotype of low kallikrein rats.
    Madeddu P; Vio CP; Straino S; Salis MB; Milia AF; Emanueli C
    Kidney Int; 2001 Jun; 59(6):2233-42. PubMed ID: 11380826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenovirus-mediated kallikrein gene delivery reduces aortic thickening and stroke-induced death rate in Dahl salt-sensitive rats.
    Zhang JJ; Chao L; Chao J
    Stroke; 1999 Sep; 30(9):1925-31; discussion 1931-2. PubMed ID: 10471446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of tissue kallikrein in prevention and recovery of gentamicin-induced renal injury.
    Bledsoe G; Shen B; Yao YY; Hagiwara M; Mizell B; Teuton M; Grass D; Chao L; Chao J
    Toxicol Sci; 2008 Apr; 102(2):433-43. PubMed ID: 18227104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kallikrein gene therapy in newborn and adult hypertensive rats.
    Chao J; Yang Z; Jin L; Lin KF; Chao L
    Can J Physiol Pharmacol; 1997 Jun; 75(6):750-6. PubMed ID: 9276159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenovirus-mediated human tissue kallikrein gene delivery inhibits neointima formation induced by interruption of blood flow in mice.
    Emanueli C; Salis MB; Chao J; Chao L; Agata J; Lin KF; MunaĆ² A; Straino S; Minasi A; Capogrossi MC; Madeddu P
    Arterioscler Thromb Vasc Biol; 2000 Jun; 20(6):1459-66. PubMed ID: 10845858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kallikrein gene transfer reduces renal fibrosis, hypertrophy, and proliferation in DOCA-salt hypertensive rats.
    Xia CF; Bledsoe G; Chao L; Chao J
    Am J Physiol Renal Physiol; 2005 Sep; 289(3):F622-31. PubMed ID: 15886273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of renal fibrosis, inflammation, and glomerular hypertrophy by kallikrein gene delivery.
    Bledsoe G; Shen B; Yao Y; Zhang JJ; Chao L; Chao J
    Hum Gene Ther; 2006 May; 17(5):545-55. PubMed ID: 16716111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.